ClinicalTrials.gg
RecruitingNCT05506085Updated Aug 14, 2026

Deep Brain Stimulation for Laryngeal Dystonia: From Mechanism to Optimal Application

An observational study in Laryngeal Dystonia and Adductor Spastic Dysphonia of Dystonia, sponsored by Indiana University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Indiana University · Observational

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Deep Brain Stimulation (DBS) is a neurosurgical procedure used to treat tremors, and dystonia. This study will enroll people who have a form of focal dystonia that affects their vocal cords called Adductor Laryngeal dystonia (ADLD). Participants will undergo Deep Brain Stimulation surgery to treat laryngeal dystonia as part of their clinical care. Before surgery, as part of the study they will have specialized testing to study the movement of the vocal cords, as well as functional magnetic resonance imaging (fMRI). While in the operating room, researchers will examine brain waves to better understand how faulty brain firing patterns lead to dystonia. After surgery, and activation of the deep brain stimulator, participants will repeat speech testing and vocal cord imaging as well as magnetic resonance imaging (MRI).

02

Conditions studied

  • Laryngeal Dystonia
  • Adductor Spastic Dysphonia of Dystonia

Browse trials for

Keywords

  • deep brain stimulation
03

In context

Dysphonia

132 studies on the registry are indexed under Dysphonia; 38 are open to participants now.

This study's planned enrollment of 12 is below the median of 123 across 40 observational studies indexed under Dysphonia.

Browse Dysphonia studies →

Lead sponsor

Indiana University is the lead sponsor of 986 studies on the registry; 198 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 118 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals presenting for routine neurology clinic appointments will be screened for clinical DBS (Deep brain stimulation) candidacy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with ADLD and ADLD plus tremor, as diagnosed by routine clinical examination by laryngologist, speech language pathologist, and neurologist.
  • Patients undergoing globus pallidus interna (GPi) deep brain stimulation (DBS) for ADLD with tremor
  • Age range of 18-80 years
  • Native speakers of American English will be recruited since there are known differences in voice and neural signals of native and non-native speakers
  • No evidence for dementia as assessed by neurologist.
  • No evidence for severe untreated mood disorder as assessed by neurologist, or as evident on self-report (Beck Depression Inventory-II score > 29, Beck Anxiety Inventory Score > 26.
  • At least 3 months since last botulinum toxin injection and the patients would need to be fully symptomatic with no residual effects of botulinum toxin on voice quality.

Exclusion criteria

Exclusion Criteria:

  • Individuals younger than 18 years and older than 80 years of age.
  • Women who plan to become pregnant during the study period or are currently breastfeeding.
  • Prior history of stroke, brain surgery, or other neurological disorder besides the one under study.
  • Prior laryngeal framework surgeries or other disorders affecting the vocal folds
  • Patients who are asymptomatic due to treatment with botulinum toxin into the vocal folds.
  • Presence of ferromagnetic implants and cardiac implants that would be to MRI
  • Gagging or discomfort that would preclude the placement of the endoscope to visualize the larynx
  • Dementia, severe depression or severe anxiety.
  • Any clinical condition or medication judged by the investigators to potentially preclude the patient from safely completing awake brain surgery and research protocols.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Patient registry
No

Groups and cohorts

  • Deep Brain Stimulation

    Voice outcomes and Magnetic resonance imaging will be compared pre- and post-DBS (Deep brain stimulation) in patients with laryngeal dystonia and adductor laryngeal dystonia. The evaluators will be masked for analyzing the voice outcomes pre-and post-DBS

    Device: Deep Brain Stimulation

Interventions

  • DeviceDeep Brain Stimulation

    Deep Brain Stimulation of Globus Pallidus interna

06

What researchers measure

Primary outcomes

  1. Change in total number of Vocal fold movements

    Vocal fold movements will be quantified (vibratory breaks + micromotions+ aperiodicities) using high-speed videoendoscopy (HSV) on sustained phonation of the vowel, words, and sentence production. The videoendoscopic recording will be obtained

    Time frame: Before surgery, within 24 hours after surgery, 6 -9 months after surgery

  2. Change in Acoustic voice recordings

    Acoustic voice recordings will be obtained using a microphone. Acoustic measurement of voice (voicing percentage) will be obtained from sustained phonation of the vowel /a/, sentences and reading a paragraph.

    Time frame: Before surgery, within 24 hours after surgery, 6-9 months after surgery

  3. Microelectrode recording

    Microelectrode recording is performed routinely during DBS (Deep brain stimulation) surgery. The study procedure will be to record voice simultaneously on sustained phonation of the vowels, syllables, and sentences using the data acquisition system NI USM 6221 with a microphone and high-speed videoendoscopy. Beta and theta band power spectral density will be analyzed as measurements.

    Time frame: during surgery

Secondary outcomes

  1. Change in Neuropsychological testing: Trails A

    Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6 months post DBS surgery (experimental) to evaluate psychomotor speed

    Time frame: Before surgery, and 6-9 months after surgery

  2. Change in Neuropsychological testin: Trails B

    Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6 months post DBS surgery (experimental) to evaluate mental flexibility

    Time frame: Before surgery, and 6-9 months after surgery

  3. Change in Neuropsychological testing: Controlled Oral Word Association Animal fluency

    Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6-9 months post DBS surgery (experimental) to evaluate verbal fluency

    Time frame: Before surgery, and 6-9 months after surgery

  4. Change in Resting state Functional Magnetic Resonance Imaging (fMRI)

    Resting state Functional Magnetic Resonance Imaging (rs-FMRI)

    Time frame: before surgery and 6-9 months after surgery

  5. Change in Voice Handicap Index

    A 30-point questionnaire to describe the voice and the effects of voice on their daily lives. The scores range from 0 to 120. 0 to 30 is a low score with minimal handicap and 61 to 120 is considered severe handicap, 31 to 60 moderate handicap

    Time frame: before surgery and 6-9 months after surgery

  6. Change in Speech Intelligibility

    will be computed from the 2nd, 3rd, and 4th sentences of the Rainbow passage as the number of correct words identified.

    Time frame: before surgery and 6-9 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Indiana University
    Indianapolis, Indiana 46202, United States
    Recruiting
    • Rita Patel, PhD · Contactpatelrir@iu.edu · 812-855-3886
    • S. Elizabeth Zauber, MD · Contactszauber@iupui.edu · 317-963-7437
    • Stacey Halum, MD · Sub investigator
    • David Kareken, PhD · Sub investigator
    • Amol Yadav, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided — De-identified data from individual patient data (IPD) will be made available to other researchers on request. We also plan to post IPD after study completion on IUScholarWorks where other researchers could access it.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05506085
Lead sponsor
Indiana University
Responsible party
Rita R. Patel (Associate Professor, Speech & Hearing Sciences, Indiana University) — Principal investigator
First posted
Aug 18, 2022
Start date
Oct 1, 2022
Primary completion
Aug 1, 2030 (estimated)
Completion
Aug 1, 2030 (estimated)
Last update
Aug 14, 2026

Study contacts

Rita Patel, PhD
Contact
patelrir@iu.edu
8128553886
S. Elizabeth Zauber, MD
Contact
szauber@iupui.edu
317-963-7437
Rita Patel, PhD
principal investigator · Indiana University
S. Elizabeth Zauber, MD
principal investigator · Indiana University
Kunal Gupta, MD, PhD
principal investigator · Indiana University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion